Inventor · disambiguated record
David A. Engers
Also filed as: ENGERS DAVID · ENGERS DAVID A · ENGERS DAVID ALAN
17 granted patents·5 pending applications·1,646 citations·filing 1995–2020
95Inventor score
Files withCELGENE CORP4OTSUKA AMERICA PHARMACEUTICAL INC3BUDENHEIM KG CHEMISCHE FABRIK2ELAN PHARMA INT LTD2LORIMER KEITH2
Top patents by PatentIndex Score
22 records- 0197US6045829ANanocrystalline formulations of human immunodeficiency virus (HIV) protease inhibitors using cellulosic surface stabilizersELAN PHARMA INT LTD·Filed 1997·Granted Apr 4, 2000·329 cites·22 claims
- 0296US6221400B1Methods of treating mammals using nanocrystalline formulations of human immunodeficiency virus (HIV) protease inhibitorsELAN PHARMA INT LTD·Filed 1999·Granted Apr 24, 2001·215 cites·13 claims
- 0395US5571536AFormulations of compounds as nanoparticulate dispersions in digestible oils or fatty acidsNANO SYS LLC·Filed 1995·Granted Nov 5, 1996·237 cites·3 claims
- 0495US5560931AFormulations of compounds as nanoparticulate dispersions in digestible oils or fatty acidsNAWOSYSTEMS L L C·Filed 1995·Granted Oct 1, 1996·272 cites·6 claims
- 0595US5518738ANanoparticulate nsaid compositionsNANOSYSTEM LLC·Filed 1995·Granted May 21, 1996·331 cites·15 claims
- 0693US6068858AMethods of making nanocrystalline formulations of human immunodeficiency virus (HIV) protease inhibitors using cellulosic surface stabilizersELAN PHARMA INTERNATIONAL LIMI·Filed 1999·Granted May 30, 2000·232 cites·18 claims
- 0789US8691872B2Dispersions of rasagiline citrateLORIMER KEITH·Filed 2011·Granted Apr 8, 2014·8 cites·9 claims
- 0888US9708261B2Crystalline compoundsNEUROVANCE INC·Filed 2016·Granted Jul 18, 2017·6 cites·32 claims
- 0987US10800740B2Crystalline compoundsOTSUKA AMERICA PHARMACEUTICAL INC·Filed 2019·Granted Oct 13, 2020·2 cites·26 claims
- 1086US9856217B2Crystalline compoundsNEUROVANCE INC·Filed 2017·Granted Jan 2, 2018·4 cites·14 claims
- 1185US11299458B2Crystalline compoundsOTSUKA AMERICA PHARMACEUTICAL INC·Filed 2020·Granted Apr 12, 2022·1 cites·10 claims
- 1284US10280141B2Crystalline compoundsOTSUKA AMERICA PHARMACEUTICAL INC·Filed 2017·Granted May 7, 2019·3 cites·40 claims
- 1382US9624271B2Romidepsin solid forms and uses thereofCELGENE CORP·Filed 2015·Granted Apr 18, 2017·2 cites·16 claims
- 1480US10793437B2Method for the manufacture of Fe(II)P/Fe(II)MetP compoundsBUDENHEIM KG CHEMISCHE FABRIK·Filed 2018·Granted Oct 6, 2020·2 cites·12 claims
- 1574US9211290B2Solid dispersions of amorphous paroxetine mesylateNOVEN THERAPEUTICS LLC·Filed 2013·Granted Dec 15, 2015·1 cites·6 claims
- 1674US8980825B2Romidepsin solid forms and uses thereofCELGENE CORP·Filed 2014·Granted Mar 17, 2015·1 cites·2 claims
- 1763US2014336132A1Romidepsin solid forms and uses thereofCELGENE CORP·Filed 2014·Application pending·0 cites
- 1857US9518094B2Romidepsin solid forms and uses thereofCELGENE CORP·Filed 2015·Granted Dec 13, 2016·0 cites·6 claims
- 1951US2021388532A1Conductive textilesBUDENHEIM KG CHEMISCHE FABRIK·Filed 2019·Application pending·0 cites
- 2050US2014194510A1Dispersions of rasagiline citrateLORIMER KEITH·Filed 2014·Application pending·0 cites
- 2149US2012190817A2Romidepsin solid forms and uses thereofHANKO JASON·Filed 2011·Application pending·0 cites
- 2246US2016136148A1Solid dispersions of amorphous paroxetine mesylateNOVEN THERAPEUTICS LLC·Filed 2015·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →